📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC. (2023)

First Author: Javitt A

Attributed to: Enhancing immunogenicity in non-viral low mutation burden tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s43018-023-00557-4

PubMed Identifier: 37217651

Publication URI: http://europepmc.org/abstract/MED/37217651

Type: Journal Article/Review

Volume: 4

Parent Publication: Nature cancer

Issue: 5

ISSN: 2662-1347